Conservative sample size estimation in nonparametrics

Journal of Biopharmaceutical Statistics

Volumn 21, Issue 1, 2011, Pages 24-41

  De Martini, Daniele ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Bootstrap; Lower bounds for the true power; Sample size estimation; Uncertainty

Indexed keywords

ARTICLE; NONPARAMETRIC TEST; PRIORITY JOURNAL; RANK SUM TEST; SAMPLE SIZE; STATISTICAL MODEL;

CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; MODELS, STATISTICAL; SAMPLE SIZE; STATISTICS, NONPARAMETRIC;

EID: 78650923989     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400903453343     Document Type: Article

References (22)

1. Arcones, M. A., Giné, E. (1992). On the bootstrap of U and V statistics. Annals of Statistics 4:655-674.
2. Bloch, D. A., Lai, T. L., Taubert-Bitter, P. (2001). One-sided tests in clinical trials with multiple endpoints. Biometrics 57:1039-1047.
3. Browne, R. H. (1995). On the use of a pilot sample for sample size determination. Statistics in Medicine 14:1933-40.
4. Chow, S. C., Shao, J., Wang, H. (2003). Sample Size Calculation in Clinical Research. Boca Raton: CRC Press.
5. Chuang-Stein, C. (2006). Sample size and the probability of a successful trial. Pharmaceutical Statistics 5:305-309.
6. Chuang-Stein, C., Stryszak, P., Dmitrienko, A., Offen, W. (2007). Challenge of multiple co-primary endpoints: a new approach. Statistics in Medicine 26:1181-1192.
7. Efron, B., Tibshirani, R. J. (1993). An Introduction to the Bootstrap. New York: Chapman & Hall.
8. Fay, M. P., Halloran, M. E., Follmann, D. A. (2007). Accounting for variability in sample size estimation with applications to nonadherence and estimation of variance and effect size. Biometrics 63:465-474.
9. Freiman, J. A., Chalmers, T. C., Smith, H., Kuebler, R. R. (1978). The importance of beta, the type II error, and sample size in the design and interpretation of the randomized controlled trial: survey of 71 "negative" trials. New England Journal of Medicine 299:690-694.
10. International Conference on Harmonization. (1998). Guidance on statistical principles for clinical trials. Federal Register 63(179):49583-49598.
11. Lehmann, E. L. (1975). Nonparametrics: Statistical Methods Based on Ranks. San Francisco: Holden Day.
12. Munzel, U., Hauschke, D. (2003). A nonparametric test for proving noninferiority in clinical trials with ordered categorical data. Pharmaceutical Statistics 2:31-37.
13. Newcombe, R. G. (2006a). Confidence intervals for an effect size measure based on the Mann-Whitney statistic. Part 1: General issues and tail-area-based methods. Statistics in Medicine 25:543-557.
14. Newcombe, R. G. (2006b). Confidence intervals for an effect size measure based on the Mann-Whitney statistic. Part 2: Asymptotic methods and evaluation. Statistics in Medicine 25:559-573.
15. Noether, G. E. (1987). Sample size determination for some common non-parametric tests. JASA 82:645-647.
16. Rosner, B. (2005). Fundamentals of Biostatistics. 6th ed. Boston: Duxbury Press.
17. Serfling, R. J. (1980). Approximation Theorems of Mathematical Statistics. New York: Wiley.
18. Spiegelhalter, D. J., Fredeman, L. S. (1986). A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. Statistics in Medicine 5:1-13.
19. Vickers, A. J. (2003). Underpowering in randomized trials reporting a sample size calculation. Journal of Clinical Epidemiology 56:717-720.
20. Wang, H., Chen, B., Chow, S. C. (2003). Sample size determination based on rank tests in clinical trials. Journal of Biopharmaceutical Statistics 13:735-751.
21. Wang, S. J., Hung, H. M. J., O'Neill, R. T. (2006). Adapting the sample size planning of a phase III trial based on phase II data. Pharmaceutical Statistics 5:85-97.
22. Zhao, Y. D., Rahardja, D., Qu, Y. (2007). Sample size calculation for the Wilcoxon-Mann-Whitney test adjusting for ties. Statistics in Medicine 27:462-468.